Mariëtte J. Weterman

Metformin in patients with advanced pancreatic cancer: a double-blind, randomised, placebo-controlled phase 2 trial

Sil Kordes, Michaël Pollak, Aeilko H. Zwinderman et al. · The Lancet Oncology · 2015 · 372 citations

Placebo-controlled Phase 2, Oncology, Pancreatic Cancer +8

Phase II study of capecitabine and the oral mTOR inhibitor everolimus in patients with advanced pancreatic cancer

Sil Kordes, Heinz‐Josef Klümpen, Mariëtte J. Weterman et al. · Cancer Chemotherapy and Pharmacology · 2015 · 67 citations · Full text

Adjuvant hepatic arterial infusion pump chemotherapy and resection versus resection alone in patients with low-risk resectable colorectal liver metastases – the multicenter randomized controlled PUMP trial

Florian E. Buisman, Marjolein Y.V. Homs, Dirk J. Grünhagen et al. · BMC Cancer · 2019 · 57 citations · Full text

A phase I/II, non-randomized, feasibility/safety and efficacy study of the combination of everolimus, cetuximab and capecitabine in patients with advanced pancreatic cancer

Sil Kordes, Dick J. Richel, Heinz‐Josef Klümpen et al. · Investigational New Drugs · 2012 · 35 citations · Full text

Phase I and pharmacokinetic study of capecitabine and the oral mTOR inhibitor everolimus in patients with advanced solid malignancies

Maarten J. Deenen, Heinz‐Josef Klümpen, Dick J. Richel et al. · Investigational New Drugs · 2011 · 23 citations · Full text